Bladder cancer: open trials in Israel

20 open trials have a site in Israel. Registry data; only the trial team decides who can take part.

NCT07206225
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Trial Treatment · Phase 1 · Pfizer
Rambam Health Care Campus, Haifa · Hadassah medical Center, Jerusalem · Rabin Medical Center, Petah Tikva · Sheba medical center, Ramat Gan
Registry updated 2026-11-05
NCT05614739
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Trial Treatment · Phase 1 · Eli Lilly and Company
Rabin Medical Center- Beilinson Hospital, Petah Tikva · Sheba medical center, Tel HaShomer
Registry updated 2026-11-04
NCT06319820
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Rambam Health Care Campus, Haifa · Sheba medical center, Ramat Gan · Ziv Medical Center, Sderot · Sourasky Medical Center, Tel Aviv · Hadassah University Hospita Ein Kerem, Yeruham
Registry updated 2026-11-03
NCT06919965
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Carmel Medical Center, Haifa · Rambam Medical Center, Haifa · Meir Medical Center, Kfar Saba · Rabin Medical Center, Petah Tikva · Sheba medical center, Ramat Gan · Tel-Aviv Sourasky Medical Center, Tel Aviv
Registry updated 2026-11-03
NCT07419295
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Rambam Health Care Campus ( Site 0362), Haifa · Shaare Zedek Medical Center ( Site 0366), Jerusalem · Rabin Medical Center ( Site 0364), Petah Tikva · Sheba Medical Center ( Site 0361), Ramat Gan · Yitzhak Shamir Medical Center. ( Site 0367), Tsrifin
Registry updated 2026-11-03
NCT07265947
Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
Trial Treatment · Phase 2 · Tyra Biosciences, Inc
Edith Wolfson Medical Center, Holon · Hadassah University Hospital - Ein Kerem, Jerusalem · Meir Medical Center, Kfar Saba · Chaim Sheba Medical Center, Ramat Gan · Tel-Aviv Sourasky Medical Center, Tel Aviv
Registry updated 2026-11-02
NCT07881666
Inactivated UPEC-FimON for Non Muscle Invasive Bladder Cancer After BCG or Intravesical Chemotherapy Failure
Trial Treatment · Phase 1 · Hopec Pharma
Hadassah medical Center, Jerusalem · Meir Medical Center, Kfar Saba · Sheba Medical Center, Tel Hashomer, Ramat Gan
Registry updated 2026-10-30
NCT07222488
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Rabin Medical Center ( Site 0062), Petah Tikva
Registry updated 2026-10-29
NCT07898033
1 Year Recurrence After Modified en Bloc Resection (ERBT) vs Transurethral Resection (TURBT) for Large Bladder Tumors
Trial Treatment · Phase 3 · dmitry enikeev
Rabin Medical Center, Petah Tikva
Registry updated 2026-10-27
NCT07232602
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Rambam Health Care Campus ( Site 5501), Haifa · Rabin Medical Center ( Site 5504), Petah Tikva
Registry updated 2026-10-02
NCT05176483
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Trial Treatment · Phase 1 · Exelixis
Beersheba · Haifa · Jerusalem · Petah Tikva · Tel Aviv · Tsrifin
Registry updated 2026-10-01
NCT05562830
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Rambam Health Care Campus-Oncology ( Site 1501), Haifa · Rabin Medical Center-Oncology ( Site 1504), Petah Tikva · Sheba Medical Center-ONCOLOGY ( Site 1503), Ramat Gan
Registry updated 2026-09-28
NCT06774131
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Trial Treatment · Phase 3 · UroGen Pharma Ltd.
Lady Davis Carmel Medical Center, Haifa · Meir Medical Center, Department of Urology, Kefar Sava · Rabin Medical Center - Hasharon hospital, Petah Tikva · Sheba medical center, Ramat Gan · Assaf Harofeh hospital, Shamir Medical Center, Tsrifin
Registry updated 2026-09-03
NCT06663137
A Study to Evaluate the Safety and Efficacy of NDV-01 in Participants With NMIBC
Trial Treatment · Phase 2 · Relmada Therapeutics, Inc.
Raanana
Registry updated 2026-09-02
NCT04895709
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Bristol-Myers Squibb
Rambam Health Care Campus, Haifa · Rabin Medical Center, Petah Tikva · Sheba medical center, Ramat Gan · Ramat Gan · Sourasky Medical Center, Tel Aviv
Registry updated 2026-08-17
NCT07106762
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Rambam Health Care Campus, Haifa · Hadassah medical Center, Jerusalem · Rabin Medical Center, Petah Tikva · Yitzhak Shamir Medical Center, Tsrifin
Registry updated 2026-07-29
NCT07728474
LCS103 Herbal Formula for Secondary Prevention of Non-Muscle Invasive Urothelial Carcinoma of the Bladder
Trial Treatment · LifeBiotic Medical Research Ltd.
Rambam Health Care Campus, Urology Department, Haifa
Registry updated 2026-07-29
NCT04879329
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Trial Treatment · Phase 2 · Seagen, a wholly owned subsidiary of Pfizer
Rambam Health Care Campus, Haifa · Rabin Medical Center, Petah Tikva · The Chaim Sheba Medical Center, Ramat Gan · Sheba medical center, Ramat Gan · Tel-Aviv Sourasky Medical Center, Tel Aviv
Registry updated 2026-07-22
NCT05296564
Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
Trial Treatment · Phase 1/2 · Hadassah Medical Organization
Hadassah Medical Organization, Jerusalem
Registry updated 2025-10-02
NCT06167057
POST URS Chemotherapy Instillation
Trial Treatment · Carmel Medical Center
Assuta Ashdod Hospital, Ashdod · Soroka University Medical Center, Beersheba · Shamir Medical Center, Be’er Ya‘aqov · Carmel Medical Center, Haifa · Bnai Zion Medical Center, Haifa · Rambam Health Care Campus, Haifa · Rabin Medical Center - Beilinson and Hasharon, Petah Tikva · Kaplan Medical Center, Rehovot · Ziv Medical Center, Safed · Tel Aviv Sourasky Medical Center Ichilov, Tel Aviv
Registry updated 2023-12-20

All Bladder cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error